Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol (Berl). 2007;114(2):97–109.
Strik HM, Marosi C, Kaina B, Neyns B. Temozolomide dosing regimens for glioma patients. Curr Neurol Neurosci Rep. 2012;12(3):286–93.
Article CAS PubMed Google Scholar
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med. 2005;352(10):987–96.
Article CAS PubMed Google Scholar
Orzan F, De Bacco F, Crisafulli G, Pellegatta S, Mussolin B, Siravegna G, et al. Genetic evolution of glioblastoma stem-like cells from primary to recurrent tumor. Stem Cells Dayt Ohio. 2017;35(11):2218–28.
Singh N, Miner A, Hennis L, Mittal S. Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist. 2021;4(1):17–43.
CAS PubMed PubMed Central Google Scholar
Moretti D, Del Bello B, Allavena G, Maellaro E. Calpains and cancer: Friends or enemies? Arch Biochem Biophys. 2014;564:26–36.
Article CAS PubMed Google Scholar
Edmunds T, Nagainis PA, Sathe SK, Thompson VF, Goll DE. Comparison of the autolyzed and unautolyzed forms of µ- and m-calpain from bovine skeletal muscle. Biochim Biophys Acta. 1991;1077:197–208.
Article CAS PubMed Google Scholar
Goll DE, Thompson VF, Taylor RG, Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? BioEssays. 1992;14(8):549–56.
Article CAS PubMed Google Scholar
Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer. 2011;11(5):364–74.
Article CAS PubMed Google Scholar
Kawasaki H, Imajoh S, Kawashima S, Hayashi H, Suzuki K. The small subunits of calcium dependent proteases with different calcium sensitivities are identical. J Biochem (Tokyo). 1986;99(5):8.
Aoki K, Imajoh S, Ohno S, Emori Y, Koike M, Kosaki G, et al. Complete amino acid sequence of the large subunit of the low-Ca 2+ -requiring form of human Ca 2+ -activated neutral protease (μCANP) deduced from its cDNA sequence. FEBS Lett. 1986;205(2):313–7.
Article CAS PubMed Google Scholar
Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature. 2008;456(7220):409–12.
Article CAS PubMed Google Scholar
Ohno S, Emori Y, Imajoh S, Kawasaki H, Kisaragi M, Suzuki K. Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? Nature. 1984;312(5994):566–70.
Article CAS PubMed Google Scholar
Sorimachi H, Mamitsuka H, Ono Y. Understanding the substrate specificity of conventional calpains. Biol Chem. 2012;393(9):853–71.
Article CAS PubMed Google Scholar
Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilágyi A, Bánóczi Z, et al. On the Sequential Determinants of Calpain Cleavage. J Biol Chem. 2004;279(20):20775–85.
Article CAS PubMed Google Scholar
Atherton J, Kurbatskaya K, Bondulich M, Croft CL, Garwood CJ, Chhabra R, et al. Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer’s disease. Aging Cell. 2014;13(1):49–59.
Article CAS PubMed Google Scholar
Kurbatskaya K, Phillips EC, Croft CL, Dentoni G, Hughes MM, Wade MA, et al. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain. Acta Neuropathol Commun. 2016;4(1):34.
Article PubMed PubMed Central Google Scholar
Trinchese F, Fa M, Liu S, Zhang H, Hidalgo A, Schmidt SD, et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest. 2008;118(8):2796–807.
Article CAS PubMed PubMed Central Google Scholar
Gao A, McCoy HM, Zaman V, Shields DC, Banik NL, Haque A. Calpain activation and progression of inflammatory cycles in Parkinson’s disease. Front Biosci-Landmark. 2022;27(1):1.
Cai JJ, Qi ZX, Hua W, Zhu JJ, Zhang X, Yao Y, et al. Increased Expression of Capn4 is Associated with the Malignancy of Human Glioma. CNS Neurosci Ther. 2014;20(6):521–7.
Article CAS PubMed PubMed Central Google Scholar
Frances CP, Conde MC, Saez ME, Diez SF, Rey CM, Ramírez-Armengol JA, et al. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility. J Gastroenterol Hepatol. 2007;22(12):2298–302.
Article CAS PubMed Google Scholar
Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC, Sharma RK. Overexpression of m-Calpain in Human Colorectal Adenocarcinomas. Cancer Epidemiol Biomark Prev. 2004;6:87.
Niapour M, Farr C, Minden M, Berger SA. Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression. Blood Cancer J. 2012;2(1):e51–e51.
Article CAS PubMed PubMed Central Google Scholar
Kulkarni S, Saju L, Farver C, Tubbs R. Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response. Int J Cancer. 2012;131(10):2420–32.
Article CAS PubMed Google Scholar
Storr SJ, Thompson N, Pu X, Zhang Y, Martin SG. Calpain in breast cancer: role in disease progression and treatment response. Pathobiology. 2015;82(3–4):133–41.
Kitagawa Y, Tanaka S, Kamiya M, Kuriki Y, Yamamoto K, Shimizu T, et al. A novel topical fluorescent probe for detection of glioblastoma. Clin Cancer Res. 2021;27(14):3936–47.
Article CAS PubMed Google Scholar
Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A. On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett. 1997;406(1–2):17–22.
Article CAS PubMed Google Scholar
Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol. 1997;17(1):460–8.
Article CAS PubMed PubMed Central Google Scholar
Pariat M, Carillo S, Molinari M, Salvat C, Debüssche L, Bracco L, et al. Proteolysis by calpains: a possible contribution to degradation of p53. Mol Cell Biol. 1997;17(5):2806–15.
Article CAS PubMed PubMed Central Google Scholar
Atencio IA, Ramachandra M, Shabram P, Demers GW. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ Mol Biol J Am Assoc Cancer Res. 2000;11(5):247–53.
Benetti R, Del Sal G, Monte M, Paroni G, Brancolini C, Schenider C. The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J. 2001;20(11):2702–14.
Article CAS PubMed PubMed Central Google Scholar
Sedarous M, Keramaris E, O’Hare M, Melloni E, Slack RS, Elce JS, et al. Calpains Mediate p53 Activation and Neuronal Death Evoked by DNA Damage *. J Biol Chem. 2003;278(28):26031–8.
Article CAS PubMed Google Scholar
Chen F, Demers LM, Vallyathan V, Lu Y, Castranova V, Shi X. Impairment of NF-kappaB activation and modulation of gene expression by calpastatin. Am J Physiol Cell Physiol. 2000;279(3):C709-716.
Article CAS PubMed Google Scholar
Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. Tumor Necrosis Factor-α-inducible IκBα Proteolysis Mediated by Cytosolic m-Calpain: a mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-κb activation*. J Biol Chem. 1999;274(2):787–94.
Article CAS PubMed Google Scholar
Small GW, Chou TY, Dang CV, Orlowski RZ. Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch Biochem Biophys. 2002;400(2):151–61.
Article CAS PubMed Google Scholar
Ruiz-Vela A, González de Buitrago G, Martínez-A C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 1999;18(18):4988–98.
Article CAS PubMed PubMed Central Google Scholar
Gafni J, Cong X, Chen SF, Gibson BW, Ellerby LM. Calpain-1 cleaves and activates caspase-7. J Biol Chem. 2009;284(37):25441–9.
留言 (0)